As part of the ongoing MDD Seminar Series, the College of Pharmacy at Gulf Medical University hosted an engaging talk on the integration of artificial intelligence (AI) in drug discovery. Titled “Artificial Intelligence in Drug Discovery and Computational Biology: Current Status, Successes, and Pitfalls”, the talk was attended by the MDD students and faculty members. The talk was delivered by Prof. Andreas Bender, a prominent figure in Molecular Informatics.
During the seminar, Prof. Bender provided MDD students with valuable insights into the latest advancements and challenges in utilizing AI for drug discovery. He discussed the rapid expansion of chemical and biological data, highlighting significant breakthroughs such as the design of functional proteins and antibodies, as well as the emergence of AI-designed drugs entering clinical trials.
Prof. Bender also shed light on the persistent challenges facing the field, including a continued reliance on reductionist approaches and limited access to relevant data. However, he encouraged MDD students to explore the potential of AI in drug discovery and to consider innovative approaches to overcome these obstacles.
As a Professor at Cambridge University and Chief Technology & Informatics Officer (CITO) at PangeAI, Prof. Bender brought a wealth of expertise to the seminar. His insights resonated with MDD students, inspiring them to delve deeper into the intersection of AI and pharmaceutical research.
The seminar served as a platform for MDD students to expand their knowledge and engage in discussions on the future of drug discovery methodologies. Attendees left the talk with a renewed enthusiasm to apply AI techniques in their research endeavors.